IP Verse

Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect - EP2992891

The patent EP2992891 was granted to UCB Pharma on Aug 5, 2020. The application was originally filed on Jun 15, 2007 under application number EP15156237A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2992891

UCB PHARMA
Application Number
EP15156237A
Filing Date
Jun 15, 2007
Status
Granted And Under Opposition
Jul 3, 2020
Publication Date
Aug 5, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBMay 3, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBWITHDRAWN

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2005EP10603
DESCRIPTIONEP1541138
DESCRIPTIONUS5378729
DESCRIPTIONUS5773475
OPPOSITIONWO2006079547

Non-Patent Literature (NPL) Citations (45) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BERENBAUM, M.C., "What is synergy?", PHARMACOL REV, (1989), vol. 41, pages 93 - 141, XP002105789
DESCRIPTION- BIALER, M.; JOHANNESSEN, S.I.; KUPFERBERG, H.J.; LEVY, R.H.; LOISEAU, P.; PERUCCA, E., "Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V", EPILEPSY RESEARCH, (2001), vol. 43, pages 11 - 58
DESCRIPTION- BOROWICZ, K.K.; KLEINROK, Z.; CZUCZWAR, S.J., "The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam", NAUNYN SCHMIEDEBERGS ARCH PHARMACOL, (2000), vol. 361, pages 629 - 35
DESCRIPTION- BOROWICZ, K.K.; SWIADER, M.; LUSZCZKI, J.; CZUCZWAR, S.J., "Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis", EPILEPSIA, (2002), vol. 43, pages 956 - 963
DESCRIPTION- BOURGEOIS, B.F.D., "Anticonvulsant potency and neurotoxicity of valproate alone and in combination with carbamazepine and phenobarbital", CLIN NEUROPHARMACOL, (1988), vol. 11, pages 348 - 59
DESCRIPTION- BOURGEOIS, B.F.D.; WAD, N., "Combined administration of carbamazepine and phenobarbital: effect on anticonvulsant activity and neurotoxicity", EPILEPSIA, (1988), vol. 29, pages 482 - 7
DESCRIPTION- BRODIE, M.J., "Do we need any more new antiepileptic drugs?", EPILEPSY RES, (2001), vol. 45, pages 3 - 6
DESCRIPTION- DUNHAM, N.W.; MIYA, T.S., "A note on a simple apparatus for detecting neurological deficit in rats and mice", J. AM. PHARM. ASSOC., (1957), vol. 46, pages 208 - 209
DESCRIPTION- EUR J PHARMACOL, (1993), vol. 230, page 389
DESCRIPTION- GOWER, A.J.; NOYER, M.; VERLOES, R. ET AL., "Ucb L059, a novel anticonvulsant drug: pharmacological profile in animals", EUR J PHARMACOL, (1992), vol. 222, pages 193 - 203
DESCRIPTION- HOVINGA, C.A., "Erlosamide Schwarz Pharma", IDRUGS, (2003), vol. 6, no. 5
DESCRIPTION- J. MARCH, Advanced Organic Chemistry, JOHN WILEY AND SONS, (1985), pages 16 - 18
DESCRIPTION- KERRY, D.W.; HAMILTON-MILLER, J.M.T.; BRUMFITT, W, "Trimethoprim and rifampicin: in vitro activities separately and in combination", J ANTIMICROB CHEMOTHER, (1975), vol. 1, pages 417 - 27
DESCRIPTION- KRAMER, G., "The limitations of antiepileptic drug monotherapy", EPILEPSIA, (1997), vol. 38, no. 5, pages S9 - S13
DESCRIPTION- LITCHFIELD, J.T.; WILCOXON, F., "A simplified method of evaluating dose-effect experiments", J. PHARMACOL EXP THER, (1949), vol. 96, pages 99 - 113
DESCRIPTION- LOISEAU, P., "DO we need novel anti-epileptic drugs?", BR. J. CLIN. PRACT., (1988), vol. 42, pages 2 - 3
DESCRIPTION- LUSZCZKI JJ; BOROWICZ KK; SWIADER M; CZUCZWAR SJ, "Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis", EPILEPSIA, (2003), vol. 44, pages 489 - 99
DESCRIPTION- LUSZCZKI, J.J.; CZUCZWAR, S.J., "Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics - a comparative study", EPILEPSY RES., (2003), vol. 56, pages 27 - 42
DESCRIPTION- PATSALOS, P.N., "Levetiracetam: pharmacology and therapeutics in the treatment of epilepsy and other neurological conditions", REV CONTEMP PHARMACOTHER, (2004), vol. 13, pages 1 - 168
DESCRIPTION- PORRECA, F.; JIANG, Q.; TALLARIDA, R.J., "Modulation of morphine antinociception by peripheral [Leu5] enkephalin: a synergistic interaction", EUR J PHARMACOL, (1990), vol. 179, pages 463 - 468
DESCRIPTION- SANDER, J.W.A.S.; SHORVON, S.D., "Incidence and prevalence studies in epilepsy and their methodological problems: a review", J. NEUROL. NEUROSURG. PHYCHIAT., (1987), vol. 50, pages 829 - 839
DESCRIPTION- TALLARIDA, R.J.; STONE, D.J.; MCCARY, J.D. ET AL., "Response surface analysis of synergism between morphine and clonidine", J PHARMACOL EXP THER, (1999), vol. 289, pages 8 - 13
DESCRIPTION- TALLARIDA, R.J.; STONE, D.J.; RAFFA, R.B., "Efficient designs for studying synergistic drug combinations", LIFE SCI, (1997), vol. 61, pages PL417 - 25
DESCRIPTION- LOSCHER, W.; HONACK, D., "Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats", EUR J PHARMACOL, (1993), vol. 232, doi:doi:10.1016/0014-2999(93)90768-D, pages 147 - 158, XP023770418
DESCRIPTION- TALLARIDA, R.J., "Statistical analysis of drug combinations for synergism", PAIN, (1992), vol. 49, doi:doi:10.1016/0304-3959(92)90193-F, pages 93 - 7, XP024379838
DESCRIPTION- LOSCHER, W.; NOLTING, B., "The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices", EPILEPSY RES, (1991), vol. 9, doi:doi:10.1016/0920-1211(91)90041-D, pages 1 - 10, XP024394354
DESCRIPTION- WARNER, T.; PATSALOS, P.N.; PREVETT, M. ET AL., "Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxide", EPILEPSY RES, (1992), vol. 11, doi:doi:10.1016/0920-1211(92)90049-Y, pages 147 - 50, XP024394370
DESCRIPTION- BIALER, M.; JOHANNESSEN, S.I.; KUPFERBERG, H.J.; LEVY, R.H.; PERUCCA, E.; TORBJORN, T., "Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII", EPILEPSY RESEARCH, (2004), vol. 61, doi:doi:10.1016/j.eplepsyres.2004.07.010, pages 1 - 48, XP004579931
DESCRIPTION- KLITGAARD, H.; MATAGNE, A.; GOBERT, J. ET AL., "Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy", EUR J PHARMACOL, (1998), vol. 353, doi:doi:10.1016/S0014-2999(98)00410-5, pages 191 - 206, XP000910515
DESCRIPTION- TALLARIDA, R.J., "The interaction index: a measure of drug synergism", PAIN, (2002), vol. 98, doi:doi:10.1016/S0304-3959(02)00041-6, pages 163 - 8, XP055071866
DESCRIPTION- BARTON, M.E.; KLEIN, B.D.; WOLF, H.H.; WHITE, H.S, "Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy", EPILEPSY RES., (2001), vol. 47, doi:doi:10.1016/S0920-1211(01)00302-3, pages 217 - 227, XP055090437
DESCRIPTION- BIALER, M.; JOHANNESSEN, S.I.; KUPFERBERG, H.J.; LEVY, R.H.; LOISEAU, P.; PERUCCA, E., "Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI", EPILEPSY RESEARCH, (2002), vol. 51, doi:doi:10.1016/S0920-1211(02)00106-7, pages 31 - 71, XP002274395
DESCRIPTION- LUSZCZKI, J.J.; CZUCZWAR, M.; KIS, J.; KRYSA, J.; PASZTELAN, I.; SWIADER, M.; CZUCZWAR, S.J., "Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis", EPILEPSIA, (2003), vol. 44, no. 8, pages 1003 - 1013, XP055492662
DESCRIPTION- DECKERS, C.L.P.; CZUCZWAR, S.J.; HEKSTER, Y.A. ET AL., "Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed", EPILEPSIA, (2000), vol. 41, doi:doi:10.1111/j.1528-1157.2000.tb00111.x, pages 1364 - 1374, XP009035157
DESCRIPTION- LUSZCZKI, J.J.; ANDRES, M.M.; CZUCZWAR, P.; CIOCZEK-CZUCZWAR, A.; RATNARAJ, N.; PATSALOS, P.N.; CZUCZWAR S.J., "Pharmacodynamic and pharmacokinetic characterization of interactions between Levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographical analysis", EPILEPSIA, (2006), vol. 47, pages 10 - 20, XP055492666
OPPOSITION- Anonymous, "UCB ANNOUNCES PROPOSED ACQUISITION OF SCHWARZ PHARMA FOR CASH AND SHARES, VALUING SCHWARZ PHARMA AT 4.4 BILLION EUROS BUILDING THE NEXT GENERATION GLOBAL BIOPHARMACEUTICAL LEADER", UCB Press release, (20060925), pages 1 - 7, UCB Press release, URL: http://hugin.info/133973/R/1077360/185588.pdf, (20210511), XP055803700
OPPOSITION- Jatuzis D., Et Al, "Evaluation of the Effect of oral Lacosamide on concomitant AED Plasma Concentrations on Patients with partial Seizures", Epilepsia (AES Proceedings), (20080101), vol. 46, no. 8, page 170, XP055492673
OPPOSITION- Kwan Patrick, Et Al, "Combination Therapy in Epilepsy", Drugs, (20060101), vol. 66, pages 1817 - 1829, XP055803695
OPPOSITION- MALAWSKA B, KULIG K, "BRIVARACETAM UCB", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, US, (20050101), vol. 06, no. 07, ISSN 1472-4472, pages 740 - 746, XP009055914
SEARCH- HORSTMANN R ET AL, "SPM 927 DOES NOT INTERACT WITH VALPROIC ACID AND CARBAMAZEPINE", MOLECULAR IMMUNOLOGY, PERGAMON, GB, (20031205), vol. 44, no. SUPPL. 09, ISSN 0161-5890, page 97, XP009028152 [Y] 1-15 * the whole document *
SEARCH- KLITGAARD H, "ANTIEPILEPTIC DRUG DISCOVERY: LESSONS FROM THE PAST AND FUTURE CHALLENGES", ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM, MUNKSGAARD, COPENHAGEN, DK, (20050101), vol. 181, ISSN 0065-1427, pages 68 - 72, XP009078178 [Y] 1-15 * the whole document *
SEARCH- MALAWSKA B ET AL, "BRIVARACETAM UCB", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, (20050101), vol. 6, no. 7, ISSN 1472-4472, pages 740 - 746, XP009055914 [Y] 1-15 * the whole document *
SEARCH- ROGAWSKI ET AL, "Diverse mechanisms of antiepileptic drugs in the development pipeline", EPILEPSY RESEARCH, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 69, no. 3, ISSN 0920-1211, (20060601), pages 273 - 294, (20060601), XP027974329 [I] 1-15 * page 275, column l, paragraph 3 - page 276, column l, paragraph 2 * * page 283, column l, paragraph 2 - page 284, column l, paragraph 2; figures 1,6 *
SEARCH- STOEHR T ET AL, "The pre-clinical profile of the novel anticonvulsant lacosamide", EPILEPSIA, RAVEN PRESS LTD, NEW YORK, US, (20050901), vol. 46, no. suppl. 6, ISSN 0013-9580, pages 373 - 374, XP009092396 [Y] 1-15 * the whole document *
SEARCH- REYNOLDS E H ET AL, "SINGLE DRUG OR COMBINATION THERAPY OF EPILEPSY?", DRUGS, ADIS INTERNATIONAL LTD, NZ, (19810101), vol. 21, no. 5, doi:10.2165/00003495-198121050-00005, ISSN 0012-6667, pages 374 - 382, XP009029147 [Y] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents